CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 60 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is 0.19 and the average weighting 1.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $180,267,308 | 53.77% |
| Vida Ventures Advisors, LLC | 3,931,818 | $35,504,317 | 38.83% |
| First Light Asset Management, LLC | 4,780,560 | $43,168,457 | 3.78% |
| Octagon Capital Advisors LP | 2,345,075 | $21,176,027 | 3.33% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $87,426,817 | 2.75% |
| TCG Crossover Management, LLC | 2,890,816 | $26,104,068 | 2.72% |
| 5AM Venture Management, LLC | 1,245,000 | $11,242,350 | 2.52% |
| Exome Asset Management LLC | 274,900 | $2,482,348 | 2.16% |
| EcoR1 Capital, LLC | 5,714,404 | $51,601,068 | 1.58% |
| Affinity Asset Advisors, LLC | 1,135,702 | $10,255,389 | 1.18% |